International Clinical Trial: Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07803835) titled 'Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Shanghai Minwei Biotechnology Co., Ltd

Condition: Essential Hypertension Healthy Volunteers

Intervention: Drug: MWX401 1 Drug: MWX401 2 Drug: MWX401 3 Drug: MWX401 4 Drug: MWX401 5

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: March 19, 2026

Target Sample Si...